Raleigh, NC, June 23, 2009 – INC Research ®, Inc., a therapeutically-focused contract research organization (CRO) with a process for delivering reliable results, today announced the addition of Tom Zoda, PhD, as senior vice president of Neuropsychiatry to its esteemed Central Nervous System (CNS) team. In this role, Dr. Zoda provides senior level oversight of all psychiatry and neurology projects on a global basis, including business development support, and drive overall growth of the CNS division.
“Tom’s clinical CNS experience in the global arena is unparalleled and we are thrilled to have him as part of our team,” said John Potthoff, COO of INC Research. “His insights into the nuances of a wide range of indications provide our customers a high level of confidence as their trials progress through our Trusted Process ®.”
Prior to joining INC Research, Dr. Zoda worked for PPD, Inc. for more than a decade. Most recently as executive director for Global Strategic Development, CNS he helped plan and direct multiple studies, including multiple sclerosis, epilepsy, Alzheimer’s disease, Parkinson’s disease, ADHD, chronic and acute pain, and various psychiatric disorders. He has also managed large multi-center trials in the areas of gastrointestinal disorders, transplantation, insomnia, anxiety, and schizophrenia for the North American division. Before joining PPD, Dr. Zoda worked for Tanox Biosystems, Inc., overseeing the development of therapeutic antibodies and vaccines for the treatment of allergy. He earned his doctoral degree in microbiology, specializing in immunology, at the University of Texas Health Science Center at San Antonio, followed by postdoctoral work at Dartmouth Medical College.
“INC Research has always maintained a remarkable reputation in managing CNS clinical trials. I am able to combine my therapeutic foresight, global experience and leadership skills to deliver top-notch customer service,” said Zoda. “The Trusted Process provides a framework that helps reduce variability and deliver repeatable results, which is what our customers value most.”
INC Research is a recognized leader in the field of CNS conducting hundreds of global trials focused on pain, neurology and psychiatry over the past 20 years. Trials have involved more than 70,000 patients at more than 6,600 sites worldwide.
About INC Research® Inc.
INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women’s health trials. The company’s The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina. For more information please visit www.incresearch.com.